Annual Retained Earnings
-$240.50 M
-$3.59 M-1.51%
December 31, 2023
Summary
- As of February 7, 2025, TCON annual retained earnings is -$240.50 million, with the most recent change of -$3.59 million (-1.51%) on December 31, 2023.
- During the last 3 years, TCON annual retained earnings has fallen by -$61.39 million (-34.28%).
- TCON annual retained earnings is now -1123.10% below its all-time high of -$19.66 million, reached on December 31, 2012.
Performance
TCON Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$246.51 M
-$2.84 M-1.17%
June 30, 2024
Summary
- As of February 7, 2025, TCON quarterly retained earnings is -$246.51 million, with the most recent change of -$2.84 million (-1.17%) on June 30, 2024.
- Over the past year, TCON quarterly retained earnings has dropped by -$6.01 million (-2.50%).
- TCON quarterly retained earnings is now -800.61% below its all-time high of -$27.37 million, reached on December 31, 2013.
Performance
TCON Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
TCON Retained Earnings Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -1.5% | -2.5% |
3 y3 years | -34.3% | -10.3% |
5 y5 years | -72.2% | -60.9% |
TCON Retained Earnings Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -15.8% | at low | -18.6% | +2.1% |
5 y | 5-year | -48.1% | at low | -51.9% | +2.1% |
alltime | all time | -1123.1% | at low | -800.6% | +2.1% |
TRACON Pharmaceuticals Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Jun 2024 | - | -$246.51 M(+1.2%) |
Mar 2024 | - | -$243.67 M(+1.3%) |
Dec 2023 | -$240.50 M(+1.5%) | -$240.50 M(-0.2%) |
Sep 2023 | - | -$240.94 M(-4.3%) |
Jun 2023 | - | -$251.70 M(+2.6%) |
Mar 2023 | - | -$245.41 M(+3.6%) |
Dec 2022 | -$236.91 M(+14.0%) | -$236.91 M(+3.0%) |
Sep 2022 | - | -$229.91 M(+2.9%) |
Jun 2022 | - | -$223.48 M(+2.9%) |
Mar 2022 | - | -$217.25 M(+4.6%) |
Dec 2021 | -$207.78 M(+16.0%) | -$207.78 M(+3.9%) |
Sep 2021 | - | -$200.06 M(+3.6%) |
Jun 2021 | - | -$193.11 M(+4.9%) |
Mar 2021 | - | -$184.17 M(+2.8%) |
Dec 2020 | -$179.11 M(+10.3%) | -$179.11 M(+2.5%) |
Sep 2020 | - | -$174.80 M(+2.3%) |
Jun 2020 | - | -$170.81 M(+2.7%) |
Mar 2020 | - | -$166.35 M(+2.5%) |
Dec 2019 | -$162.33 M | -$162.33 M(+2.5%) |
Sep 2019 | - | -$158.40 M(+3.4%) |
Jun 2019 | - | -$153.20 M(+4.3%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | -$146.87 M(+5.2%) |
Dec 2018 | -$139.66 M(+33.4%) | -$139.66 M(+5.9%) |
Sep 2018 | - | -$131.90 M(+7.4%) |
Jun 2018 | - | -$122.82 M(+8.6%) |
Mar 2018 | - | -$113.06 M(+8.0%) |
Dec 2017 | -$104.70 M(+22.3%) | -$104.70 M(+6.7%) |
Sep 2017 | - | -$98.14 M(-1.2%) |
Jun 2017 | - | -$99.31 M(+7.1%) |
Mar 2017 | - | -$92.75 M(+8.3%) |
Dec 2016 | -$85.60 M(+46.1%) | -$85.60 M(+8.0%) |
Sep 2016 | - | -$79.28 M(+8.0%) |
Jun 2016 | - | -$73.41 M(+12.7%) |
Mar 2016 | - | -$65.12 M(+11.1%) |
Dec 2015 | -$58.59 M(+71.4%) | -$58.59 M(+23.2%) |
Sep 2015 | - | -$47.54 M(+15.7%) |
Jun 2015 | - | -$41.10 M(+7.7%) |
Mar 2015 | - | -$38.17 M(+11.7%) |
Dec 2014 | -$34.18 M(+24.9%) | -$34.18 M(+8.1%) |
Sep 2014 | - | -$31.63 M(+15.6%) |
Dec 2013 | -$27.37 M(+39.2%) | -$27.37 M |
Dec 2012 | -$19.66 M | - |
FAQ
- What is TRACON Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for TRACON Pharmaceuticals?
- What is TRACON Pharmaceuticals annual retained earnings year-on-year change?
- What is TRACON Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for TRACON Pharmaceuticals?
- What is TRACON Pharmaceuticals quarterly retained earnings year-on-year change?
What is TRACON Pharmaceuticals annual retained earnings?
The current annual retained earnings of TCON is -$240.50 M
What is the all time high annual retained earnings for TRACON Pharmaceuticals?
TRACON Pharmaceuticals all-time high annual retained earnings is -$19.66 M
What is TRACON Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, TCON annual retained earnings has changed by -$3.59 M (-1.51%)
What is TRACON Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of TCON is -$246.51 M
What is the all time high quarterly retained earnings for TRACON Pharmaceuticals?
TRACON Pharmaceuticals all-time high quarterly retained earnings is -$27.37 M
What is TRACON Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, TCON quarterly retained earnings has changed by -$6.01 M (-2.50%)